Evidence map›Paper›PMID 38101460›Full record

ArticleMatrix biology : journal of the International Society for Matrix Biology2024

Identification of Periostin as a critical niche for myofibroblast dynamics and fibrosis during tendon healing.

Jessica E Ackerman, Samantha N Muscat, Emmanuela Adjei-Sowah, Antonion Korcari, Anne E C Nichols, Mark R Buckley, Alayna E Loiselle

Open access · greenAbstract read
In one paragraph

Article in Matrix biology : journal of the International Society for Matrix Biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Identification and characterization of POSTNJournal of orthopaedic translation · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Developmental, but not Homeostatic, Collagen V Expression Regulates Mature Murine Supraspinatus Tendon Structure, Function, and Gene Expression.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2026
    Article
  11. Article
  12. CoordinatedeLife · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Loss ofMatrix biology plus · 2025
    Article
  19. Pharmacological antagonism of Ccr2+ cell recruitment to facilitate regenerative tendon healing.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2025
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Jessica E AckermanCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, United States; NDORMS, University of Oxford, Oxford, United Kingdom.
Samantha N MuscatCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, United States; Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, United States.
Emmanuela Adjei-SowahCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, United States; Department of Biomedical Engineering, University of Rochester, Rochester, NY, United States.
Antonion KorcariCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, United States; Department of Biomedical Engineering, University of Rochester, Rochester, NY, United States.
Anne E C NicholsCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, United States; Department of Orthopaedics & Physical Performance, University of Rochester Medical Center, Rochester, NY, United States.
Mark R BuckleyCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, United States; Department of Biomedical Engineering, University of Rochester, Rochester, NY, United States.
Alayna E LoiselleCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, United States; Department of Biomedical Engineering, University of Rochester, Rochester, NY, United States; Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, United States; Department of Orthopaedics & Physical Performance, University of Rochester Medical Center, Rochester, NY, United States. Electronic address: alayna_loiselle@urmc.rochester.edu.
University of Rochester Medical Center · US

Funding

Rochester Resource-Based Center for Bone, Muscle and Orthopaedic Research (ROCSTARR) (Overall Application)P30AR069655 · NIAMS · UNIVERSITY OF ROCHESTER · PI Edward M. Schwarz · 2016 to 2026
$7.8M
Modulating Cell-fate to Promote Regenerative Tendon HealingR01AR077527 · NIAMS · UNIVERSITY OF ROCHESTER · PI LOISELLE, ALAYNA · 2021 to 2025
$2.0M
s100a4 Signaling in Fibrotic Diabetic Tendon HealingR01AR073169 · NIAMS · UNIVERSITY OF ROCHESTER · PI LOISELLE, ALAYNA · 2018 to 2022
$1.7M
Epitenon-derived progenitor cells in tendon healing and adaptationR00AR080757 · NIAMS · UNIVERSITY OF ROCHESTER · PI Anne E.C. Nichols · 2024 to 2026
$727k
Epitenon-derived progenitor cells in tendon healing and adaptationK99AR080757 · NIAMS · UNIVERSITY OF ROCHESTER · PI NICHOLS, ANNE E.C. · 2022 to 2023
$283k
Myofibroblast mediated mechanisms of fibrotic tendon healingF31AR077398 · NIAMS · UNIVERSITY OF ROCHESTER · PI ACKERMAN, JESSICA EVE · 2020 to 2021
$92k
NIAMS NIH HHS F31 AR077398NIAMS NIH HHS K99 AR080757NIAMS NIH HHS P30 AR069655NIAMS NIH HHS R00 AR080757NIAMS NIH HHS R01 AR073169NIAMS NIH HHS R01 AR077527
6 · The paper itself

Abstract

Tendon injuries are a major clinical problem, with poor patient outcomes caused by abundant scar tissue deposition during healing. Myofibroblasts play a critical role in the initial restoration of structural integrity after injury. However, persistent myofibroblast activity drives the transition to fibrotic scar tissue formation. As such, disrupting myofibroblast persistence is a key therapeutic target. While myofibroblasts are typically defined by the presence of αSMA+ stress fibers, αSMA is expressed in other cell types including the vasculature. As such, modulation of myofibroblast dynamics via disruption of αSMA expression is not a translationally tenable approach. Recent work has demonstrated that Periostin-lineage (Postn

Indexed as

CicatrixMyofibroblastsCell DifferentiationFibrosisHumansPeriostinTendonsPeriostinExtracellular matrixPeriostinScar tissueTendon

Identifiers

PMID38101460
PMCPMC10922883
OpenAlexW4389670043

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.